1. Van Amerongen P. Double blind controlled trial of antidepressant action of amineptine. Curr Med Res Opin 1979; 6:93-100.

2. Deniker P, Bes an Lon G, Colonna L, et al. Etude multicentrique extensive de 1354 observations de sujets deprimes traites par Pamineptine. Encephale 1982; 8:355-70.

3. Rosier Y. L’emploi de l’amineptine daus le traitement de la depression. Psychol Med 1979; 11:211-23.

4. Haroon Ahmed S, Imtiazul H. Amineptine dependence. J Pak Med Assoc 1994; 44(9):222-3.

5. Biondi F, Di Rubbo R, Faraveilli C, Mannaioni PF. Chronic amineptine abuse. Biol Psychiatry 1990; 28:1004-6.

6. Prieto JM, Gost A, Obiols J, Caycedo N, Amineptine dependence and schizophrenia. Biol Psychiatry 1994; 36: 266-8.

7. Le Bricquir Y, Larrey D, Blanc P, Pageaux GP, Michel H. Tianeptine _ an instance of drug induced hepatotoxicity predicted by prospective experimental studies. J Hepatol 1994; 21:771-3.

8. Le Dinh T, Freneaux E, Labbe G, Letteron P, Degott C, Geneve J, et al. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1988; 247:745-50.

9. Edwards G. The treatment of drinking problems. London: Grant McIntyre G, 1982.

10. Edwards G, Busch C (eds). Drug problems in Britain: A review of 10 years. New York: Academic Press, 1981.